期刊文献+

蛋白激酶C在软脂酸诱导HepG_2细胞胰岛素抵抗中的作用

Role of protein kinase C in insulin resistance induced by palmitate in HepG_2 cells
下载PDF
导出
摘要 目的从蛋白激酶C(PKC)信号通路角度,探讨游离脂肪酸(FFA)引起肝脏胰岛素抵抗(IR)的可能机制。方法培养HepG2细胞,同时设立对照组、软脂酸(PA)组、高胰岛素组。软脂酸组、高胰岛素组分别用250μmol/L PA、5×10-7mol/L胰岛素处理24h。然后对照组、软脂酸组再根据胰岛素刺激前加(+)与不加(-)PKC抑制剂白屈菜红碱盐酸盐(chelerythrine chloride,CC)5μmol/L预处理1h,随机分为两亚组:对照组(-)、对照组(+)、PA组(-)、PA组(+)。葡萄糖氧化酶法测定胰岛素刺激后12h葡萄糖消耗量,蒽酮法测定胰岛素刺激后3h点细胞内糖原含量,Western blotting技术检测15min点细胞内P-Ser473PKB、P-Ser21/9GSK-3α/β水平。结果PA组(-)与高胰岛素组葡萄糖消耗量无统计学差异(P=0.523)。葡萄糖消耗量、细胞内糖原含量、P-Ser473PKB、P-Ser21GSK-3α、P-Ser9GSK-3β水平均显示,PA组(-)与对照组(-)比较显著降低(P值依次为0.000,0.000,0.004,0.004,0.028),对照组(+)与对照组(-)比较略有升高但无显著性差异;PA组(+)与PA组(-)比较显著升高(P值依次为0.000,0.014,0.043,0.041,0.035)。结论PA(250μmol/L)体外成功诱导了HepG2细胞产生IR,PKC信号通路在FFA引起肝脏IR中起着重要作用。 Objective To explore the possible mechanism of insulin resistance (IR) for HepG2 cells induced by high concentrations of palmitate (PA) through protein kinase C (PKC) signaling pathway analysis. Methods The model of hepatic IR was established induced by PA. HepG2 cells were randomly divided into control group,PA group (250 μmol/L PA) and high insulin group (50 nmol/L insulin) and treated for 24 hours. Then beth of control group and PA group were redivided into subgroups:control( - ) .control( + ) .PA( - ) .PA( + ). Only control( + ) and PA( + ) groups were pretreated by 5 μmol/L chelerythrine chloride (CC) of PKC inhibitor for 1 h before insulin stimulation. Insulin -stimulated glucose consumption was measured using the glucose oxidase method at 12-hour time point. Cell glycogen was measured with anthrone method at 3-hour time point and protein levels of phosphate-protein kinase B (P-Set473 PKB) and phosphate-glycogen synthase kinase (P-Ser21/9 GSK-3α/13) at 15-min time point were determined in total cell lysates by Westem-blotting. Results There was no significant difference in glucose consumption between PA(-) group and high insulin group (P = 0. 523 ). All levels of glucose consumption, glycogen content,P-Set473 PKB, P-Ser21 GSK-3et and P-Set9 GSK-3β in PA (-) group were reduced significantly ( P = 0. 000, 0. 000,0. 004,0. 004,0. 028 respectively) compared with those in control( - ) group, and were increased significantly( P = 0. 000,0. 014, 0. 043,0. 041,0. 035 respectively) in PA( + ) group compared with those in PA( - ) group. Conclusions The model of hepatic insulin resistance is established successfully. Overaction of PKC may play an important role in inducing IR in HepG2 cells.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2007年第12期1136-1138,共3页 Chinese Journal of Gerontology
基金 湖北省自然科学基金项目(2003ABA137) 湖北省卫生厅科研项目(NX200403)
关键词 胰岛素抵抗 脂肪酸 蛋白激酶C 蛋白激酶B 糖原合酶激酶 Insulin resistance Fatty acid Protein kinase C Protein kinase B Glycogen synthase kinase
  • 相关文献

参考文献4

二级参考文献35

  • 1朱道银,朱汉林,李伟,王毅,秦亚恬,裴润芳.泌尿生殖道沙眼衣原体分离培养方法探讨[J].重庆医科大学学报,1993,18(3):229-232. 被引量:1
  • 2王艳林,余斌杰,袁敏生,张怡坚,肖亦斌.过氧钒烟酸对糖尿病鼠磷酸烯醇型丙酮酸羧化酶的影响[J].中山医科大学学报,1997,18(1):13-15. 被引量:6
  • 3朱忠勇.实用医学检验学[M].北京:人民军医出版社,1998.1084.
  • 4Gurnell M,Savage DB,Chatterjee VK et al.The metabolic syndrome:Peroxisome proliferator-activated receptor gamma and its therapeutic modulation[J].J Clin Endocrinol Metab,2003,88(6):2412-21.
  • 5Tadayyon M,Smith SA.Insulin sensitisation in the treatment of Type diabetes[J].Expert Opin Investig Drugs,2003,12(3):307-24.
  • 6Melin B,Cherqui G,Blivet MJ et al.Dual effect of metformin in cultured rat hepatocytes:potentiation of insulin action and prevention of insulin-induced insulin resistance[J].Metabolism,1990,39:1089.
  • 7Arakawa K,Ishihara T,Auto M et al.Action of novel antidiabetic thiazolidinedione,T-174,in animals of non-insulin-dependent diabetes mellitus(NIDDM) and in cultured muscle cells[J].Br J Pharmacol,1998,125:429-36.
  • 8Senn JJ,Klover PJ,Nowak IA et al.Interleukin-6 induces cellular insulin resistance in hepatocytes[J].Diabetes,2002,51(12):3391-9
  • 9Bernal MC,Weng S,Finck BN et al.Dexamethasone induction of hypertension and diabetes is PPAR-alpha dependent in LDL receptor-null mice[J].Nat Med,2003,9(8):1069-75.
  • 10Camp HS.Thiazolidinediones in diabetes:Current status and future outlook[J].Curr Opin Investig Drugs,2003,4(4):406-11.

共引文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部